These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18604769)

  • 1. [Monitoring of the misuse of prescription drugs by clients of outpatient addiction treatment centres (PHAR-MON, formerly: Ebis-med). Monitoring of medication misuse].
    Küfner H; Rösner S
    Gesundheitswesen; 2008 May; 70(5):305-14. PubMed ID: 18604769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
    Darredeau C; Barrett SP; Jardin B; Pihl RO
    Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
    Hughes AA; Bogdan GM; Dart RC
    Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [www.drugcom.de--an Internet based information and counselling project for the prevention of addiction].
    Jordan S
    Prax Kinderpsychol Kinderpsychiatr; 2005 Nov; 54(9):742-54. PubMed ID: 16305021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addiction severity assessment tool: development of a self-report measure for clients in substance abuse treatment.
    Butler SF; Budman SH; McGee MD; Davis MS; Cornelli R; Morey LC
    Drug Alcohol Depend; 2005 Dec; 80(3):349-60. PubMed ID: 15994028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal observation of a sample of German drug consumption facility clients.
    Scherbaum N; Specka M; Schifano F; Bombeck J; Marrziniak B
    Subst Use Misuse; 2010; 45(1-2):176-89. PubMed ID: 20025446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence of buprenorphine consumption in a sample of outpatient drug abusers].
    Seguí J; Cascio A; Aragón C; Llovet JM; Soler JM; Salvador L
    Rev Clin Esp; 1991 Jun; 189(1):14-7. PubMed ID: 1924919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse of prescription drugs and the risk of addiction.
    Compton WM; Volkow ND
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S4-7. PubMed ID: 16563663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of patients with alcohol- or drug problems in medical practices "addiction" in Mecklenburg-Vorpommern].
    Röske K; Riedel J; Hapke U; Wosniak R; Doese D; Ohde L; John U
    Gesundheitswesen; 2004 Mar; 66(3):190-5. PubMed ID: 15088224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription and misuse of benzodiazepines in the Federal Republic of Germany.
    Müller-Oerlinghausen B
    Pharmacopsychiatry; 1986 Jan; 19(1):8-13. PubMed ID: 2870514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
    Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of temporal changes of abuse and misuse of prescription opioids.
    Spiller H; Bailey JE; Dart RC; Spiller SS
    J Addict Dis; 2010 Jan; 29(1):78-83. PubMed ID: 20390701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug misuse: is technology friend or foe?
    Nielsen S; Barratt MJ
    Drug Alcohol Rev; 2009 Jan; 28(1):81-6. PubMed ID: 19320680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of persistent pain with out-patient addiction treatment outcomes and service utilization.
    Caldeiro RM; Malte CA; Calsyn DA; Baer JS; Nichol P; Kivlahan DR; Saxon AJ
    Addiction; 2008 Dec; 103(12):1996-2005. PubMed ID: 18855809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single and multiple agency clients in substance abuse treatment services.
    Colpaert K; Vanderplasschen W; Broekaert E
    Eur Addict Res; 2007; 13(3):156-66. PubMed ID: 17570912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol abuse and suicidal behaviour.
    Veranic LZ; Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):236-8. PubMed ID: 18587297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal association between frequency of substance use and quality of life among adolescents receiving a brief outpatient intervention.
    Becker SJ; Curry JF; Yang C
    Psychol Addict Behav; 2009 Sep; 23(3):482-90. PubMed ID: 19769432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.